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The aim of the study was to find out the potential prognostic value of prolifera-
tion activity and apoptosis in cholesteatoma and granulation tissue removed
during middle ear reoperation in recurrent middle ear inflammation.
Granulation tissues and recurrent cholesteatoma were analysed after being sur-
gically removed from the middle ear in a group of 25 patients qualified for
middle ear reoperation procedure. Paraffin sections were stained with haema-
toxylin and eosin according to Mallory’s method. Immunohistochemical reac-
tion Anti-PCNA was performed. Apoptosis was evaluated using the TUNEL meth-
od. The percentage of PCNA-positive cells was 42–95% in the matrix of the
cholesteatoma and 29–81% in the perimatrix. In the granulation tissue it was
35–75%. The percentage of apoptotic cells was 12–73% in the matrix of the
cholesteatoma, 5–72% in the perimatrix and 1–65 % in the granulation tissue.
The prognostic value of the parameters studied in the recurrent middle ear in-
flammatory process is questionable, probably due to the small number of cases
under examination.
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INTRODUCTION
Recurrence of the inflammatory process follow-
ing middle ear surgery is assessed as amounting to
5–33% of surgically treated cases. In most cases of
recurrent inflammatory process in the middle ear the
most frequent findings in the postoperative cavity are
cholesteatoma and/or granulation tissue. The factors
which contribute to failure in the surgical treatment
of chronic otitis media appear to be the duration and
aggressiveness of the inflammatory process and in-
adequate surgical technique. The aim of the study
was to find out the potential prognostic value of pro-
liferation activity and apoptosis in cholesteatoma and
granulation tissue removed during middle ear reop-
eration in recurrent middle ear inflammation.
MATERIAL AND METHODS
Granulation tissues and recurrent cholesteatoma
were analysed after being surgically removed from
the middle ear in a group of 25 patients qualified
for reoperation procedure.
The group of patients studied was composed of
14 females and 11 males aged 25–71 years (mean:
43.6 years). The duration of the chronic otitis media
symptoms (based on past otologic history) was in the
range 4–52 years (mean: 22.7 years). The interval af-
ter the previous surgery ranged from 2 to 40 years
(mean: 11.7 years). The number of previous oto-
surgical procedures on the ear before inclusion in
the present study ranged from 1 to 4. Paraffin sec-
tions were stained with haematoxylin and eosin
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according to Mallory’s method. For the immuno-
histochemical reaction Anti-Proliferating Cell Nu-
clear Antingen-PCNA Clone PC10 (Dako) was used.
Apoptosis evaluation was performed using the
TUNEL method with In Situ Cell Death detection
Kit, POD (Roche).
RESULTS
Granulation tissue was observed in 14 patients
(56%) and recurrent cholesteatoma in 11 cases
(44%). In both granulation tissue and cholesteato-
ma positive PCNA cells were observed. The percent-
age of PCNA positive cells in the matrix of the cho-
lesteatoma was 42–95%, while in the perimatrix of
the cholesteatoma it was 29–81% (Fig. 1). A positive
reaction for PCNA cells in granulation tissue was
observed in 35–75% of the cells studied (Fig. 2).
Apoptotic cells in the matrix of the cholesteato-
ma varied from 12 to 73%, while in the perimatrix it
was 5–72% (Fig. 3).
The percentage of apoptotic cells in the granula-
tion tissue ranged from 1 to 65% (Fig. 4).
DISCUSSION
The higher proliferation activity found in the matrix
of the cholesteatoma confirms previous observations
by other authors [1, 2, 5, 7]. It appears to be correlated
with the natural proliferation activity of the cells in the
parabasal layer. In comparison to the normal skin sam-
ples [5] proliferation activity in the epithelial layers anal-
ysed is significantly higher. The higher number of apo-
ptotic cells in the matrix of the cholesteatoma may be
explained by decreasing proliferating activity in a su-
prabasal direction starting from the parabasal epithe-
lial layer and also by simultaneous cell ageing.
The similar values of the proliferation activity and
apoptosis observed in the perimatrix of the choleste-
atoma and granulation tissue may be due to the pro-
cess of angiogenesis [3, 4, 6].
In our study no statistically significant differenc-
es were found between proliferation activity and
apoptosis in cholesteatoma and granulation tissue.
The results obtained suggest that patient age and
the duration of the inflammatory process may have
no influence on proliferation activity and apoptosis
Figure 1. PCNA, cholesteatoma; M — matrix, P — perimatrix.
Enl. 150 ¥.
Figure 2. PCNA, granulation tissue. Enl. 150 ¥.
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Figure 4. Apoptosis, granulation tissue. Enl. 150 ¥.Figure 3. Apoptosis, cholesteatoma; M — matrix, P — perimatrix.
Enl. 150 ¥.
in the middle ear qualified for reoperation. The prog-
nostic value of the parameters studied in recurrent
middle ear inflammatory process is questionable,
probably due to a small number of cases studied.
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